Breakthroughs in Diabetes Care Glucose Monitoring Devices Market

The global glucose monitoring devices market size is expected to be valued at USD 2.31 billion in 2024 and reach USD 3.13 billion by 2029, growing at a CAGR of 6.24 % from 2024 to 2029.

Glucose monitoring devices detect the sugar level in the blood. They consist of glucose meters, testing strips, and lancets. The patient can self-test using a single glucose meter and different strips.

Global Glucose Monitoring Devices Market Report Scope:
• Market Size (2029): USD 3.13 Billion
• Market Size (2024): USD 2.31 Billion
• CAGR (2024 to 2029): 6.24 %
• Base Year: 2023
• Forecast Period: 2024 to 2029
• Segments Analysed: Device Type, Application, and Region.
• Geographies Covered: North America, Europe, APAC, Latin America, and Middle East & Africa.
• Key Market Players Profiled Roche Diagnostics, LifeScan, Bayer Health care, Abbott Diabetes, AgaMatrix Inc., Arkray Inc., Medtronic, DexCom Inc., Nova Biomedical Corporation, Terumo Europe NV. Are playing a dominant role in the global Glucose Monitoring Devices Market.

The growing prevalence of diabetes worldwide contributes to the expansion of glucose monitoring devices in the market due to the broad adoption of these devices. According to an article published by The Lancet, it is projected that over 1.31 billion individuals worldwide could be affected by diabetes by the year 2050. The growing government initiatives to increase people's awareness of diabetes and continuous monitoring fuels the market growth. The U.S. Food and Drug Administration allowed personal glucose meters and continuous glucose monitoring devices in hospitals during the pandemic, which highly impacted the worldwide market expansion. The escalating technological advancements in the development of monitoring devices, making the results more accurate, user-friendly, and better connected to healthcare providers, propels market share growth. According to WHO, diabetes is a long-lasting metabolic disorder characterized by high blood glucose levels resulting in damage to various organs. The long-term disease condition demands frequent monitoring of glucose levels, which enhances the market revenue. There are growing cases of obesity across the globe, as obesity is the leading cause of diabetes in the general population. The increasing investments by the market players to enhance the geographical reach of the products augment the global market revenue. The growing mergers, acquisitions, and collaborations among the market players lead to market growth due to increasing company portfolios with market revenue enhancements. As per the WHO report, there are 422 million diabetic patients present worldwide, where 1.5 million deaths occur annually. This increases the demand for continuous glucose monitoring, which adjusts the medication dosage. Specific advantages like comfort, easy accessibility, self-testing, and others are causing the adoption of glucose monitoring devices to increase, accelerating market growth.

The high cost of glucose monitoring devices is expected to limit the adoption of the devices by hampering the global market growth. The presence of expensive strips and needles increases the overall cost of the device, which is difficult to afford for people from low or middle-income economic backgrounds. Another restraining factor is the absence of insurance coverage or reimbursement policies in many hospitals, as diabetes is not considered under insurance. Several complications associated with blood glucose monitoring devices, such as misreading, skin irritation, and adhesive issues, are all expected to impede the market growth worldwide.

Browse full details of the report @ https://www.marketdataforecast.com/market-reports/global-glucose-monitoring-device-market

Key Insights from The Report:
• Based on device type, the continuous wearable devices segment led the market and accounted for the largest share of the global market in 2023.
• Based on Application, the hospital segment held the highest share of the global market in 2023.
• North America dominated the glucose monitoring devices market in 2023. Europe accounted for second-highest share of the global market in 2023 and on the other hand, the Asia-Pacific region is estimated to grow at the fastest CAGR during the forecast period.
• Market Leaders Profiled Roche Diagnostics, LifeScan, Bayer Health care, Abbott Diabetes, AgaMatrix Inc., Arkray Inc., Medtronic, DexCom Inc., Nova Biomedical Corporation, Terumo Europe NV are dominated the glucose monitoring devices market.

SEGMENTATION INCLUDED IN THIS REPORT:
By Device Type:
• Continuous Wearable Devices
• Self-Monitoring Devices
By Application:
• Hospitals
• Clinics and Diagnostic Centers
• Home Setting
• Ambulatory Settings
By Region:
• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East and Africa

Browse Regional Reports:
North America Glucose Monitoring Device Market Research Report - Segmented By Device Type, Application & Country (United States, Canada, Mexico & Rest of North America) - Industry Analysis on Size, Share, Trends, COVID-19 Impact & Growth Forecast (2024 to 2029) - https://www.marketdataforecast.com/market-reports/north-america-glucose-monitoring-device-market
Europe Glucose Monitoring Device Market Research Report - Segmented By Device Type, Application & Country (UK, France, Spain, Germany, Italy, Russia, Sweden, Denmark, Switzerland, Netherlands, Turkey, Czech Republic and Rest of Europe) - Industry Analysis on Size, Share, Trends, COVID-19 Impact & Growth Forecast (2024 to 2029) - https://www.marketdataforecast.com/market-reports/europe-glucose-monitoring-device-market
Asia-Pacific Glucose Monitoring Device Market Research Report - Segmented By Device Type, Application & Country (India, China, Japan, South Korea, Australia, New Zealand, Thailand, Malaysia, Vietnam, Philippines, Indonesia, Singapore and Rest of APAC) - Industry Analysis, Size, Share, Trends & Growth Forecast (2024 to 2029) - https://www.marketdataforecast.com/market-reports/asia-pacific-glucose-monitoring-device-market
Latin America Glucose Monitoring Device Market Research Report - Segmented By Device Type, Application & Country (Brazil, Argentina, Chile and Rest of Latin America) - Industry Analysis on Size, Share, Trends, COVID-19 Impact & Growth Forecast (2024 to 2029) - https://www.marketdataforecast.com/market-reports/latin-america-glucose-monitoring-device-market
Middle East & Africa Glucose Monitoring Device Market Research Report - Segmented By Device Type, Application & Country (KSA, UAE, Israel, rest of GCC countries, South Africa, Ethiopia, Kenya, Egypt, Sudan, rest of MEA) - Industry Analysis on Size, Share, Trends, COVID-19 Impact & Growth Forecast (2024 to 2029) - https://www.marketdataforecast.com/market-reports/middle-east-and-africa-glucose-monitoring-device-market

TABLE OF CONTENTS:
1. Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 New Developments
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 By Device Type
5.1.1 Continuous Wearable Devices
5.1.2 Self-Monitoring Devices
5.2 By Application
5.2.1 Hospitals
5.2.2 Clinics and Diagnostic Centers
5.2.3 Home Setting
5.2.4 Ambulatory Settings
6. Geographical Analysis
6.1 North America
6.1.1 Introduction
6.1.2 United States
6.1.3 Canada
6.2 Europe
6.2.1 Introduction
6.2.2 U.K
6.2.3 Spain
6.2.4 Germany
6.2.5 Italy
6.2.6 France
6.3 Asia-Pacific
6.3.1 Introduction
6.3.2 China
6.3.3 India
6.3.4 Japan
6.3.5 South Korea
6.3.6 Australia
6.4 Latin America
6.4.1 Introduction
6.4.2 Brazil
6.4.3 Mexico
6.4.4 Argentina
6.4.5 Rest of Latin America
6.5 Middle East & Africa
6.5.1 Introduction
6.5.2 Middle-East
6.5.3 Africa
7. Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter's Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8. Market Leaders' Analysis
8.1 Roche Diagnostics
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Strategic Evaluation and Operations
8.1.4 Financial analysis
8.1.5 Legal issues
8.1.6 Recent Developments
8.1.7 SWOT analysis
8.1.8 Analyst View
8.2 LifeScan
8.3 Bayer Health care
8.4 Abbott Diabetes care Inc
8.5 AgaMatrix Inc
8.6 Arkray Inc
8.7 Medtronic
8.8 DexCom Inc
8.9 Nova Biomedical Corporation
8.10 Teruma Europe NV
9. Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10. Expert Opinions
10.1 Market Outlook
10.2 Investment Opportunities
Appendix
a) List of Tables
b) List of Figures

Contact Us:
Market Data Forecast
www.marketdataforecast.com
Phone: +1-888-702-9626
Email: sales@marketdataforecast.com
5th Floor, Trendz Pride, Patrika Nagar Rd Number 1, HUDA Techno Enclave, HITEC City, Hyderabad, Telangana 500081, India

Market Data Forecast is a firm working in the areas of market research, business intelligence and consulting. We have rich experience in research and consulting for various business domains to cater to the needs of both individual and corporate clients.

This release was published on openPR.